NO20075690L - Avlevering av tigesyklin i naervaer av heparin - Google Patents

Avlevering av tigesyklin i naervaer av heparin

Info

Publication number
NO20075690L
NO20075690L NO20075690A NO20075690A NO20075690L NO 20075690 L NO20075690 L NO 20075690L NO 20075690 A NO20075690 A NO 20075690A NO 20075690 A NO20075690 A NO 20075690A NO 20075690 L NO20075690 L NO 20075690L
Authority
NO
Norway
Prior art keywords
heparin
tiger
cyclin
delivery
tigecycline
Prior art date
Application number
NO20075690A
Other languages
English (en)
Norwegian (no)
Inventor
Pooja Gandhi
Stephen A Ludwig
Maja Vencl-Joncic
Joseph Gross
Julianna Koczone
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20075690L publication Critical patent/NO20075690L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO20075690A 2005-05-06 2007-11-08 Avlevering av tigesyklin i naervaer av heparin NO20075690L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67820305P 2005-05-06 2005-05-06
PCT/US2006/016860 WO2006121713A2 (en) 2005-05-06 2006-05-02 Delivery of tigecycline in the presence of heparin

Publications (1)

Publication Number Publication Date
NO20075690L true NO20075690L (no) 2008-01-31

Family

ID=36973003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075690A NO20075690L (no) 2005-05-06 2007-11-08 Avlevering av tigesyklin i naervaer av heparin

Country Status (14)

Country Link
US (1) US20060251705A1 (ko)
EP (1) EP1877064A2 (ko)
JP (1) JP2008540431A (ko)
KR (1) KR20080005599A (ko)
CN (1) CN101171016A (ko)
AU (1) AU2006244588A1 (ko)
BR (1) BRPI0611070A2 (ko)
CA (1) CA2607143A1 (ko)
CR (1) CR9491A (ko)
MX (1) MX2007013895A (ko)
NO (1) NO20075690L (ko)
RU (1) RU2007140956A (ko)
WO (1) WO2006121713A2 (ko)
ZA (1) ZA200709510B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102595895B1 (ko) * 2015-11-27 2023-10-31 삼성전자 주식회사 상황인식 리소스 핫플러그 관리 시스템 및 방법
US20210161918A1 (en) * 2018-01-10 2021-06-03 The University Of North Carolina At Chapel Hill Tigecycline for topical treatment of root canal space
US11504468B2 (en) * 2018-10-23 2022-11-22 Abk Biomedical Incorporated Delivery device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
PT1301207E (pt) * 2000-06-30 2005-11-30 Pharmacia & Upjohn Co Llc Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilina
CA2631632A1 (en) * 2005-12-22 2007-07-05 Wyeth Methods of treating gastrointestinal tract infections with tigecycline

Also Published As

Publication number Publication date
JP2008540431A (ja) 2008-11-20
EP1877064A2 (en) 2008-01-16
RU2007140956A (ru) 2009-06-20
CN101171016A (zh) 2008-04-30
CA2607143A1 (en) 2006-11-16
ZA200709510B (en) 2008-11-26
WO2006121713A2 (en) 2006-11-16
MX2007013895A (es) 2008-01-28
KR20080005599A (ko) 2008-01-14
BRPI0611070A2 (pt) 2010-08-03
US20060251705A1 (en) 2006-11-09
AU2006244588A1 (en) 2006-11-16
CR9491A (es) 2008-02-21
WO2006121713A3 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
TW200744568A (en) Epinephrine dosing regimens
PH12014500053A1 (en) Proteasome inhibitors
PH12018500641A1 (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
NO20092637L (no) Fremgangsmater for behandling
MX2012000396A (es) Metodos y composiciones para uso en tartamientos celulares.
MY160041A (en) Compositions and methods for treating parasitic infections
MX2009013332A (es) Inhibidores de ire-1 alfa.
MA32161B1 (fr) Formes de rifaximine et utilisations de celles-ci
CL2010001426A1 (es) Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
EA201101521A1 (ru) Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
TW200716646A (en) (S)-N-methylnaltrexone
MX2015002371A (es) Inhibidores bivalentes de las proteinas iap y metodos terapueticos que usan los mismos.
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
AR048819A1 (es) Metodos sinergicos y composiciones para el tratamiento del cancer
NO20082120L (no) Behandling og forebyggelse av mikroangiopati
MY149606A (en) Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
EA200801676A1 (ru) Комбинация производных триазина и сенсибилизаторов инсулина
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
IN2014DN08385A (ko)
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application